CMV_AcrIIA4_cpGR2(GGS5)-ΔN64_Q65_E66
(Plasmid
#246052)
-
PurposeExpression of AcrIIA4-cpGR2 hybrid in mammalian cells after Bubeck et al Nat Methods 2018; enables chemogenetic control of SpyCas9
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 246052 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepcDNA3.1
-
Vector typeMammalian Expression, CRISPR, Synthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAcrIIA4_cpGR2-ΔN64/Q65/E66
-
SpeciesSynthetic
-
MutationΔN64/Q65/E66
Cloning Information
- Cloning method Golden Gate
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CMV_AcrIIA4_cpGR2(GGS5)-ΔN64_Q65_E66 was a gift from Dominik Niopek (Addgene plasmid # 246052 ; http://n2t.net/addgene:246052 ; RRID:Addgene_246052) -
For your References section:
A versatile anti-CRISPR platform for opto- and chemogenetic control of CRISPR-Cas9 and Cas12 across a wide range of orthologs. Brenker L, Aschenbrenner S, Bubeck F, Staykov K, Gebhardt C, Wolf B, Jendrusch M, Kroll AS, Becker J, Ambiel I, Fackler OT, Grimm D, Mathony J, Niopek D. Nucleic Acids Res. 2025 Jul 19;53(14):gkaf752. doi: 10.1093/nar/gkaf752. 10.1093/nar/gkaf752 PubMed 40794863